In this episode of Everything GLP-1, Dr. Tom Lavin speaks with Gibb Clark, CEO of YourEra Healthcare, a direct-to-consumer healthcare platform operating in all 50 states, to explore what sets personalized, high-touch care models apart in a crowded telehealth landscape. Rather than framing direct-to-consumer healthcare as a simple medication delivery service, Gibb describes a comprehensive model built around patient care coordinators, in-house pharmacy and provider groups, and expanding wellness offerings.

Together, they discuss why the first months of a patient's GLP-1 journey are often the most fragile, how ongoing communication between patients and providers drives better outcomes, and how emerging categories like NAD+ and Sermorelin fit into a broader healthcare optimization strategy. Dr. Tom Lavin adds clinical context throughout, grounding the conversation in real patient outcomes.

It is an informative discussion for clinicians, healthcare leaders, and anyone interested in how personalized infrastructure and patient engagement are shaping the future of GLP-1 care.

[00:00] Introducing YourEra Healthcare

[01:26] What Sets YourEra Apart

[06:11] Launching YourEra Optimum

[08:30] Keys to GLP-1 Success

[15:54] Inside YourEra's Own Pharmacy

[20:07] Living at Your Ideal Weight

[22:52] GLP-1s Reshaping Industries

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Everything GLP-1, Dr. Lavin speaks with Dr. Matthew French, a physician with 25 years of experience in weight loss treatment and Dr. Lavin's longtime surgical partner in bariatric surgery, to explore what sustainable success on GLP-1 therapy actually requires. Rather than framing results around maximum doses or rigid protocols, the conversation centers on individualized titration, consistent follow-up, and recognizing when a patient's hunger and cravings signal the need for adjustment.

Dr. Matthew French explains his approach of keeping patients on the lowest effective dose, while Dr. Lavin discusses the shift toward long-term microdosing for maintenance and metabolic benefit. Together, they discuss virtual versus in-office care, the risks of automatic dose escalation common in some telehealth models, and the broader health benefits patients experience beyond weight loss, including reduced inflammation and decreased cravings for alcohol and unhealthy foods.

It's a practical, experience-driven discussion for clinicians, healthcare leaders, and anyone seeking a clearer understanding of how personalized dosing and attentive follow-up drive lasting outcomes on GLP-1 therapy.

Hosted on Acast. See acast.com/privacy for more information.

In this episode of Everything GLP-1, Dr. Lavin sits down with Dan and Belinda Simile to share a personal account of what GLP-1 therapy can look like when it works as intended. Dan, a 64-year-old man who spent decades managing high blood pressure, high cholesterol, weight fluctuations, and an eventual prediabetes diagnosis despite consistent exercise and effort, describes losing 28 to 30 pounds in just 11 weeks through YourEra.

Together, they discuss the biology behind food noise and cravings, the frustration of the weight-loss roller coaster, and how personalized dosing helped Dan avoid side effects while steadily improving his blood pressure and lipid panels. Belinda offers a candid perspective on her early skepticism and what changed her mind, while Dan reflects on discipline, commitment, and reframing his health struggle as a journey rather than a battle.

This is a candid, encouraging discussion for clinicians, patients, and anyone navigating the gap between effort and results in their own health journey.

Hosted on Acast. See acast.com/privacy for more information.